Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2026-02-26 @ 12:36 AM
Study NCT ID:
NCT03823118
Status:
COMPLETED
Last Update Posted:
2023-02-23
First Post:
2019-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
S1 Plus Anlotinib in Treating Patients With Refractory or Relapsed Small-cell Lung Cancer
Sponsor:
Taizhou Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-17
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-28
First Submit QC Date:
None
Study First Post Date:
2019-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-22
Last Update Post Date:
2023-02-23
Last Update Post Date Type:
ACTUAL